Evaluation of a sorbitol dehydrogenase inhibitor on diabetic peripheral nerve metabolism: a prevention study
dc.contributor.author | Obrosova, I. G. | en_US |
dc.contributor.author | Greene, Douglas A. | en_US |
dc.contributor.author | Fathallah, L. | en_US |
dc.contributor.author | Lang, H. J. | en_US |
dc.date.accessioned | 2006-09-08T19:44:36Z | |
dc.date.available | 2006-09-08T19:44:36Z | |
dc.date.issued | 1999-09 | en_US |
dc.identifier.citation | Obrosova, I. G.; Fathallah, L.; Lang, H. J.; Greene, D. A.; (1999). "Evaluation of a sorbitol dehydrogenase inhibitor on diabetic peripheral nerve metabolism: a prevention study." Diabetologia 42(10): 1187-1194. <http://hdl.handle.net/2027.42/41886> | en_US |
dc.identifier.issn | 0012-186X | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/41886 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=10525658&dopt=citation | en_US |
dc.description.abstract | Aims/hypothesis . Studies of the role of sorbitol dehydrogenase in nerve functional deficits induced by diabetes reported contradictory results. We evaluated whether sorbitol dehydrogenase inhibition reduces metabolic abnormalities and enhances oxidative stress characteristic of experimental diabetic neuropathy. Methods . Control and streptozotocin-diabetic rats were treated with or without sorbitol dehydrogenase inhibitor (SDI)-157 (100 mg · kg –1 · day –1 , in the drinking water, for 3 weeks). Sciatic nerve free mitochondrial (cristae and matrix) and cytosolic NAD + : NADH ratios were calculated from the β -hydroxybutyrate, glutamate and lactate dehydrogenase systems. Concentrations of metabolites, e. g. sorbitol pathway intermediates and variables of energy state were measured in individual nerves spectrofluorometrically by enzymatic procedures. Results . The flux through sorbitol dehydrogenase (manifested by nerve fructose concentrations) was inhibited by 53 % and 74 % in control and diabetic rats treated with SDI compared with untreated control and diabetic groups. Free NAD + :NADH ratios in mitochondrial cristae, matrix and cytosol were decreased in diabetic rats compared with controls and reduction in either of the three variables was not prevented by sorbitol dehydrogenase inhibitor. Phosphocreatine concentrations and phosphocreatine:creatine ratios were decreased in diabetic rats compared with controls and were further reduced by the inhibitor. Malondialdehyde plus 4-hydroxyalkenals concentration was increased and reduced gluthathione concentration was reduced in diabetic rats compared with the control group, and changes in both variables were further exacerbated by sorbitol dehydrogenase inhibitor. Neither NAD-redox and energy states nor lipid aldehyde and reduced gluthathione concentrations were affected by treatment with the inhibitor in control rats. Conclusion/interpretation . Inhibition of sorbitol dehydrogenase does not offer an effective approach for prevention of oxidation and metabolic imbalances in the peripheral nerve that is induced by diabetes and is adverse rather than beneficial. [Diabetologia (1999) 42: 1187–1194] | en_US |
dc.format.extent | 110890 bytes | |
dc.format.extent | 3115 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Springer-Verlag; Springer-Verlag Berlin Heidelberg | en_US |
dc.subject.other | Energy Metabolism | en_US |
dc.subject.other | Keywords Rat | en_US |
dc.subject.other | Legacy | en_US |
dc.subject.other | NAD-redox State | en_US |
dc.subject.other | Oxidative Stress | en_US |
dc.subject.other | Streptozotocin-diabetes | en_US |
dc.subject.other | Sorbitol Dehydrogenase Inhibitor | en_US |
dc.title | Evaluation of a sorbitol dehydrogenase inhibitor on diabetic peripheral nerve metabolism: a prevention study | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan, USA, US, | en_US |
dc.contributor.affiliationum | Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan, USA, US, | en_US |
dc.contributor.affiliationum | Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan, USA, US, | en_US |
dc.contributor.affiliationother | Hoechst Marion Roussel Deutschland GmbH, Chemical Research Frankfurt, Frankfurt/Main, Germany, DE, | en_US |
dc.contributor.affiliationumcampus | Ann Arbor | en_US |
dc.identifier.pmid | 10525658 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/41886/1/125-42-10-1187_90421187.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1007/s001250051290 | en_US |
dc.identifier.source | Diabetologia | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.